Quest Diagnostics
DGX
#1081
Rank
ยฃ15.44 B
Marketcap
ยฃ138.11
Share price
0.86%
Change (1 day)
11.05%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): ยฃ6.55

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is ยฃ6.48. In 2024 the company made an earnings per share (EPS) of ยฃ5.83 an increase over its 2023 EPS that were of ยฃ5.69.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ6.5512.31%
2024ยฃ5.832.5%
2023ยฃ5.69-5.83%
2022ยฃ6.04-49.21%
2021ยฃ11.9049.72%
2020ยฃ7.9566.67%
2019ยฃ4.7718%
2018ยฃ4.04-4.26%
2017ยฃ4.2223.19%
2016ยฃ3.43-7.11%
2015ยฃ3.6928.46%
2014ยฃ2.87-31.61%
2013ยฃ4.2060.46%
2012ยฃ2.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
ยฃ7.69 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-ยฃ0.53-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ0.66-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ0.16-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ1.40-78.37%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands